Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01540383Not ApplicableCompleted

Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions

Role: collaborator

NCT07270484Not ApplicableCompleted

Rehabilitation Based on Hybrid Neuroprosthesis

Role: collaborator

NCT02231060Completed

Study for the Improvement of Long-Term Outcome Prediction in Patients in Coma After Cardiac Arrest

Role: collaborator

NCT01397500Phase 2Terminated

Hormone Treatment in Growth Hormone and Testosterone Deficient Patients

Role: collaborator

NCT01834443Not ApplicableUnknown

Therapeutic Effects of Galvanic Vestibular Stimulation (GVS) on Spatial Neglect

Role: lead

All 5 trials loaded